Art

J-GLOBAL ID：200902226182884626   Reference number：08A0801115

Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate

メシル酸イマチニブによる黒色腫での化学療法薬透過性の改善

Author (5)： OGAWA Youichi (Dep. of Dermatology, Fac. of Medicine, Univ. of Yamanashi, Yamanashi 409-3898, JPN) ,  KAWAMURA Tatsuyoshi (Dep. of Dermatology, Fac. of Medicine, Univ. of Yamanashi, Yamanashi 409-3898, JPN) ,  FURUHASHI Masao (Dep. of Dermatology, Fac. of Medicine, Univ. of Yamanashi, Yamanashi 409-3898, JPN) ,  TSUKAMOTO Katsuhiko (Dep. of Dermatology, Yamanashi Prefecture Central Hospital, Yamanashi 400-0027, JPN) ,  SHIMADA Shinji (Dep. of Dermatology, Fac. of Medicine, Univ. of Yamanashi, Yamanashi 409-3898, JPN)
Material： Journal of Dermatological Science  (J Dermatol Sci)
Volume： 51  Issue： 3  Page： 190-199  Publication year： Sep. 2008 
JST Material Number： W1280A  ISSN： 0923-1811  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *antitumor drug ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0801115&from=J-GLOBAL&jstjournalNo=W1280A") }}

JST classification (1)： Basic research of antitumor(=antineoplastic)drugs  (GW16010A)

Substance index (2)： imatinib mesilate ,  Dacarbazine

Reference (32)：

• DRUKER, BJ. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996, 2, 561-566
• BUCHDUNGER, E. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000, 295, 139-145
• HEINRICH, MC. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 2000, 96, 925-932
• DRUKER, BJ. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia. N Engl J Med. 2001, 344, 1031-1037
• DEMETRI, GD. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002, 347, 472-480

Terms in the title (4)： メシル酸イマチニブ ,  黒色腫 ,  化学療法薬 ,  透過性